Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.53
-4.44 (-1.74%)
AAPL  337.17
-2.58 (-0.76%)
AMD  614.99
-8.78 (-1.41%)
BAC  56.04
-0.16 (-0.28%)
GOOG  338.29
-9.12 (-2.63%)
META  754.86
+18.27 (2.48%)
MSFT  498.64
+0.64 (0.13%)
NVDA  225.71
-3.16 (-1.38%)
ORCL  147.14
-2.06 (-1.38%)
TSLA  381.23
+2.33 (0.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.